Godspower Onavbavba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Godspower Onavbavba has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Obi Peter Adigwe
National Institute for Pharmaceutical Research and Development Abuja Federal Capital Territory Nigeria
18 shared publications Anthony Ayeke
European Union Delegation to the Federal Republic of Nigeria and ECOWAS, Abuja, Federal Capital Territory, Nigeria
2 shared publicationsDiana Oyin-Mieyebi Wilson
National Institute for Pharmaceutical Research and Development, Abuja, Nigeria
2 shared publications- Diana Oyin-Mieyebi Wilson
Office of the Director General, National Institute for Pharmaceutical Research and Development, Abuja, Federal Capital Territory, Nigeria
2 shared publications Kenneth Anene Agu
Howard University Global Institute Nigeria, Abuja, Federal Capital Territory, Nigeria
2 shared publicationsOlajide Joseph Adebola
Home Plus Medicare Services Ltd. F1, Police Cooperative Estate, Obot Akara Street, Beside Army Estate Kubwa, Abuja, Federal Capital Territory, Nigeria
2 shared publications
Latest Publications
- Open Access
- 4 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
The Role of Research, Quality Improvement, and Training in Achieving Medicines Security in Nigeria: A Cross‐Sectional Exploration of Stakeholders' Perspectives
Background and Aims: Equitable access to medicines remains a challenge in Nigeria with issues such as sub‐optimal national pharmaceutical production capacities and the need to improve relevant quality standards. Thus, in order to identify context‐specific solutions to this challenge, this study aimed to assess the perspectives of stakeholders in the healthcare value chain on the role of quality improvement and capacity‐building strategies relevant to expediting medicines security in Nigeria. Methods: A national cross‐sectional survey was conducted in Nigeria using a multistage sampling technique. A pretested questionnaire was administered to relevant stakeholders in the health sector. Descriptive and inferential statistical analyses were undertaken using Statistical Package for Social Sciences (SPSS) software version 25. Results: A total of 416 questionnaires were retrieved. Just over a third of the study participants (37.9%) surveyed were actively employed in the pharmaceutical manufacturing sector. Nearly all the participants (94.8%) believed regulatory authorities should ensure the stringent implementation of Good Manufacturing Practices to sustain consistency in the quality of medicines. Similarly, over three‐quarters of the study cohort (86.1%) indicated that the pharmaceutical sector, as well as relevant agencies in the industry, should be prioritised by the government, as this was critical in achieving medicines security. Also, a strong majority of the participants indicated that attaining the World Health Organization pre‐qualification status was necessary to ensure access to high‐quality medicines. There was a significant association between the participants' sociodemographic characteristics and key study variables. A higher proportion of the respondents with more than 5 years of experience agreed that investment in research and development was important to improve the quality of medicines, and this was statistically significant ( p = 0.009). Conclusion: This cross‐sectional study highlights strategic areas based on stakeholders' perceptions where interventions and reforms can be channelled to support efforts towards expediting the achievement of medicines security in Nigeria.
- 4 August 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Open AccessThe Role of Research, Quality Improvement, and Training in Achieving Medicines Security in Nigeria: A Cross‐Sectional Exploration of Stakeholders' Perspectives
Background and Aims: Equitable access to medicines remains a challenge in Nigeria with issues such as sub‐optimal national pharmaceutical production capacities and the need to improve relevant quality standards. Thus, in order to identify context‐specific solutions to this challenge, this study aimed to assess the perspectives of stakeholders in the healthcare value chain on the role of quality improvement and capacity‐building strategies relevant to expediting medicines security in Nigeria. Methods: A national cross‐sectional survey was conducted in Nigeria using a multistage sampling technique. A pretested questionnaire was administered to relevant stakeholders in the health sector. Descriptive and inferential statistical analyses were undertaken using Statistical Package for Social Sciences (SPSS) software version 25. Results: A total of 416 questionnaires were retrieved. Just over a third of the study participants (37.9%) surveyed were actively employed in the pharmaceutical manufacturing sector. Nearly all the participants (94.8%) believed regulatory authorities should ensure the stringent implementation of Good Manufacturing Practices to sustain consistency in the quality of medicines. Similarly, over three‐quarters of the study cohort (86.1%) indicated that the pharmaceutical sector, as well as relevant agencies in the industry, should be prioritised by the government, as this was critical in achieving medicines security. Also, a strong majority of the participants indicated that attaining the World Health Organization pre‐qualification status was necessary to ensure access to high‐quality medicines. There was a significant association between the participants' sociodemographic characteristics and key study variables. A higher proportion of the respondents with more than 5 years of experience agreed that investment in research and development was important to improve the quality of medicines, and this was statistically significant ( p = 0.009). Conclusion: This cross‐sectional study highlights strategic areas based on stakeholders' perceptions where interventions and reforms can be channelled to support efforts towards expediting the achievement of medicines security in Nigeria.
- Open Access
- 23 June 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1768068
Knowledge, awareness, and perception of healthcare professionals towards Long COVID in Nigeria
Introduction: Long COVID is a complex condition with prolonged symptoms that develop after COVID-19 infection and continue beyond 12 weeks. This study aimed to assess healthcare professionals’ knowledge, awareness, and perceptions of Long COVID in Nigeria. Methods: A cross-sectional study using multistage random sampling was conducted amongst licensed healthcare professionals in Nigeria, including physicians, pharmacists, nurses, and medical laboratory scientists. A validated questionnaire was administered to practitioners in selected health facilities. Data from 405 respondents were analysed using the Statistical Package for the Social Sciences (SPSS) version 25. Results: A total of 405 valid responses were obtained, reflecting a response rate of 81%. Male and female participants were of similar proportions, as indicated by 50.1 and 49.9%, respectively. Over a quarter (26.3%) of the sample were not aware of Long COVID, and of the respondents who had heard about the condition, more than half (58.5%) indicated that they obtained their information from the internet. Participants’ understanding of Long COVID was assessed to be limited, with a mean knowledge score of 6.38 ± 2.86. As indicated by more than half (50.5%) of the study cohort, there is a lack of prioritisation in the management of post-COVID symptoms in Nigeria, as well as inadequate frameworks to mitigate the effects of the condition (45.1%). Male participants had significantly higher knowledge scores than females, with p = 0.006 and a standardised beta coefficient of 0.158, indicating a small-to-moderate effect size. Conclusion: The study identified knowledge gaps amongst healthcare professionals in Nigeria regarding Long COVID and provides baseline evidence to inform the development of diagnostic, preventive, and context-appropriate management strategies for the condition.
- 23 June 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1768068
Open AccessKnowledge, awareness, and perception of healthcare professionals towards Long COVID in Nigeria
Introduction: Long COVID is a complex condition with prolonged symptoms that develop after COVID-19 infection and continue beyond 12 weeks. This study aimed to assess healthcare professionals’ knowledge, awareness, and perceptions of Long COVID in Nigeria. Methods: A cross-sectional study using multistage random sampling was conducted amongst licensed healthcare professionals in Nigeria, including physicians, pharmacists, nurses, and medical laboratory scientists. A validated questionnaire was administered to practitioners in selected health facilities. Data from 405 respondents were analysed using the Statistical Package for the Social Sciences (SPSS) version 25. Results: A total of 405 valid responses were obtained, reflecting a response rate of 81%. Male and female participants were of similar proportions, as indicated by 50.1 and 49.9%, respectively. Over a quarter (26.3%) of the sample were not aware of Long COVID, and of the respondents who had heard about the condition, more than half (58.5%) indicated that they obtained their information from the internet. Participants’ understanding of Long COVID was assessed to be limited, with a mean knowledge score of 6.38 ± 2.86. As indicated by more than half (50.5%) of the study cohort, there is a lack of prioritisation in the management of post-COVID symptoms in Nigeria, as well as inadequate frameworks to mitigate the effects of the condition (45.1%). Male participants had significantly higher knowledge scores than females, with p = 0.006 and a standardised beta coefficient of 0.158, indicating a small-to-moderate effect size. Conclusion: The study identified knowledge gaps amongst healthcare professionals in Nigeria regarding Long COVID and provides baseline evidence to inform the development of diagnostic, preventive, and context-appropriate management strategies for the condition.
- Open Access
- 28 May 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (5) , e0006124
Perception of artificial intelligence and machine learning applications in the Nigerian healthcare sector: A cross-sectional study
Artificial intelligence (AI) has significant benefits across various facets of healthcare delivery, notably in personalised pharmacotherapy and the development of targeted health interventions for specific demographic groups. This study aimed to comprehensively evaluate the applications of AI and machine learning (ML) from the perspectives of healthcare professionals in Nigeria . A cross-sectional study design was adopted, and responses were obtained from healthcare professionals across the six geopolitical zones in Nigeria. Data were collected with the aid of a well-structured questionnaire, and a stratified multistage sampling method was employed. Statistical Package for Social Sciences (SPSS) software version 25 was used to analyse the data generated. The results of descriptive analysis and inferential analysis were generated and discussed appropriately. Pharmacists (27.7%), physicians (24.5%), and nurses (19.3%) comprised the largest professional groups, with females representing 55.7% of participants. Most respondents (68.3%) were aged 18–30 years. Two-thirds (67.3%) agreed that ML algorithms can enhance research processes, and a similar proportion (69.5%) believed AI could accelerate drug discovery. Regarding clinical decision-making, 66.6% indicated that AI can support physicians by processing unstructured data, while 77% felt AI and ML could improve pharmaceutical manufacturing. This study revealed positive perceptions from healthcare professionals regarding the applications of AI and ML in the Nigerian health sector. The findings from this study indicate the readiness of the health workforce for a large-scale implementation of AI technologies in the sector.
- 28 May 2026
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (5) , e0006124
Open AccessPerception of artificial intelligence and machine learning applications in the Nigerian healthcare sector: A cross-sectional study
Artificial intelligence (AI) has significant benefits across various facets of healthcare delivery, notably in personalised pharmacotherapy and the development of targeted health interventions for specific demographic groups. This study aimed to comprehensively evaluate the applications of AI and machine learning (ML) from the perspectives of healthcare professionals in Nigeria . A cross-sectional study design was adopted, and responses were obtained from healthcare professionals across the six geopolitical zones in Nigeria. Data were collected with the aid of a well-structured questionnaire, and a stratified multistage sampling method was employed. Statistical Package for Social Sciences (SPSS) software version 25 was used to analyse the data generated. The results of descriptive analysis and inferential analysis were generated and discussed appropriately. Pharmacists (27.7%), physicians (24.5%), and nurses (19.3%) comprised the largest professional groups, with females representing 55.7% of participants. Most respondents (68.3%) were aged 18–30 years. Two-thirds (67.3%) agreed that ML algorithms can enhance research processes, and a similar proportion (69.5%) believed AI could accelerate drug discovery. Regarding clinical decision-making, 66.6% indicated that AI can support physicians by processing unstructured data, while 77% felt AI and ML could improve pharmaceutical manufacturing. This study revealed positive perceptions from healthcare professionals regarding the applications of AI and ML in the Nigerian health sector. The findings from this study indicate the readiness of the health workforce for a large-scale implementation of AI technologies in the sector.
- Open Access
- 5 March 2026
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 24 (1)
Catalysing vaccines research, development and manufacturing in Nigeria: a qualitative exploration of industry stakeholders’ knowledge, perceptions and experience
Background: The lack of local production of vaccines in Nigeria is a challenge contributing to limited access to healthcare. To address these vulnerabilities, the nation has committed efforts toward vaccine self-sufficiency through local production. However, this initiative has been met with a plethora of constraints. These include inadequate technical capacity, insufficient resources, limited infrastructure, procurement challenges, cold chain management, uncertain market mechanisms and a lack of funding. This study, therefore, aims to bridge this gap by articulating robust strategies for local vaccine production from the perspective of relevant stakeholders across different areas of the vaccine value chain. Methods: A qualitative strategy was adopted to explore participants’ perspectives on the strategies for sustainable local vaccine manufacturing in Nigeria. The study sample represented stakeholders practising across different areas of the vaccine value chain. Data obtained were analysed thematically to yield themes and sub-themes. Trustworthiness in the study was ensured through recommended frameworks. Results: Following data analysis, nine overarching themes were identified, which articulated the need to build capacity and an enabling environment for vaccine development in Nigeria. The findings showed that inadequate research capacity, weak infrastructure and poor commercialization frameworks constrain vaccine production, necessitating phased production initiation, strengthened research systems, infrastructural development and improved market access. Effective management and advocacy were found to be critical for securing government and stakeholders’ commitment, as well as reducing vaccine hesitancy to support sustainable local vaccine production. Conclusions: This study provides in-depth insights into the strategies for expediting the national objective to achieve vaccine self-sufficiency, including the establishment of an enabling policy and legislative environment to attract investment, streamline regulation and secure market access for locally produced vaccines. It emphasizes strengthening research and development capacity beyond fill-and-finish activities, addressing workforce skills gaps through training and technology transfer, and improving infrastructure through reliable power supply and vaccine industrial parks. Overall, the findings highlight the need for sustainable financing, stakeholder coordination, and strong government interventions to ensure the viability of local vaccine manufacturing. These insights can guide effective planning and comprehensive efforts into the requisite areas necessary for sustainable vaccine manufacturing in the country.
- 5 March 2026
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 24 (1)
Open AccessCatalysing vaccines research, development and manufacturing in Nigeria: a qualitative exploration of industry stakeholders’ knowledge, perceptions and experience
Background: The lack of local production of vaccines in Nigeria is a challenge contributing to limited access to healthcare. To address these vulnerabilities, the nation has committed efforts toward vaccine self-sufficiency through local production. However, this initiative has been met with a plethora of constraints. These include inadequate technical capacity, insufficient resources, limited infrastructure, procurement challenges, cold chain management, uncertain market mechanisms and a lack of funding. This study, therefore, aims to bridge this gap by articulating robust strategies for local vaccine production from the perspective of relevant stakeholders across different areas of the vaccine value chain. Methods: A qualitative strategy was adopted to explore participants’ perspectives on the strategies for sustainable local vaccine manufacturing in Nigeria. The study sample represented stakeholders practising across different areas of the vaccine value chain. Data obtained were analysed thematically to yield themes and sub-themes. Trustworthiness in the study was ensured through recommended frameworks. Results: Following data analysis, nine overarching themes were identified, which articulated the need to build capacity and an enabling environment for vaccine development in Nigeria. The findings showed that inadequate research capacity, weak infrastructure and poor commercialization frameworks constrain vaccine production, necessitating phased production initiation, strengthened research systems, infrastructural development and improved market access. Effective management and advocacy were found to be critical for securing government and stakeholders’ commitment, as well as reducing vaccine hesitancy to support sustainable local vaccine production. Conclusions: This study provides in-depth insights into the strategies for expediting the national objective to achieve vaccine self-sufficiency, including the establishment of an enabling policy and legislative environment to attract investment, streamline regulation and secure market access for locally produced vaccines. It emphasizes strengthening research and development capacity beyond fill-and-finish activities, addressing workforce skills gaps through training and technology transfer, and improving infrastructure through reliable power supply and vaccine industrial parks. Overall, the findings highlight the need for sustainable financing, stakeholder coordination, and strong government interventions to ensure the viability of local vaccine manufacturing. These insights can guide effective planning and comprehensive efforts into the requisite areas necessary for sustainable vaccine manufacturing in the country.
- Open Access
- 30 December 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 4363
A qualitative exploration of critical issues limiting local vaccines production in Nigeria: lessons from the COVID-19 pandemic
Background: Vaccines are essential health interventions that have become a cost-effective tool for maintaining public health. Access to vaccines in Nigeria and other developing countries is, however, affected by various relevant issues, including insufficient supply, inequitable distribution, vaccine hesitancy, and a lack of local manufacturing capacity. This study, therefore, aimed to gain an in-depth understanding of the challenges impeding vaccine production in Nigeria, taking lessons from the COVID-19 pandemic. Method: A qualitative study was undertaken using a purposive sampling strategy to recruit key stakeholders across Nigeria’s vaccine value chain. Interviews were carried out using a semi-structured interview guide. Relevant stakeholders with varying levels of experience across the vaccine value chain were interviewed to ensure that robust and comprehensive data were obtained. The data collected were subjected to thematic analysis, following the interpretivist tradition. Throughout the study, trustworthiness was assured by adopting relevant processes such as data triangulation, reflexive and audit trails. Ethical approval was obtained from the National Institute for Pharmaceutical Research and Development Health Research Ethics Committee prior to the commencement of data collection. Results: This study revealed eight thematic areas underpinning the gaps associated with local vaccine production in Nigeria. Challenges included limited capacity, inadequate research and development, infrastructure deficits, and a sub-optimal environment for vaccine development. Furthermore, the challenges associated with commercialisation and distribution were identified. Findings also revealed a lack of critical factors required for expediting vaccine manufacturing in Nigeria, including poor commitment to collaboration, an absence of sustainability policies and sub-optimal legislation. Conclusion: The study provides insight into systemic and structural barriers to local vaccine production in Nigeria. It identifies key areas requiring urgent intervention, which include funding, infrastructure, human capacity, and regulatory reform. Addressing these gaps through multi-level strategies is critical for improving vaccine self-sufficiency. Evidence from this study can help develop contextual strategies that will expedite vaccine production and Medicines’ Security in Nigeria.
- 30 December 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 4363
Open AccessA qualitative exploration of critical issues limiting local vaccines production in Nigeria: lessons from the COVID-19 pandemic
Background: Vaccines are essential health interventions that have become a cost-effective tool for maintaining public health. Access to vaccines in Nigeria and other developing countries is, however, affected by various relevant issues, including insufficient supply, inequitable distribution, vaccine hesitancy, and a lack of local manufacturing capacity. This study, therefore, aimed to gain an in-depth understanding of the challenges impeding vaccine production in Nigeria, taking lessons from the COVID-19 pandemic. Method: A qualitative study was undertaken using a purposive sampling strategy to recruit key stakeholders across Nigeria’s vaccine value chain. Interviews were carried out using a semi-structured interview guide. Relevant stakeholders with varying levels of experience across the vaccine value chain were interviewed to ensure that robust and comprehensive data were obtained. The data collected were subjected to thematic analysis, following the interpretivist tradition. Throughout the study, trustworthiness was assured by adopting relevant processes such as data triangulation, reflexive and audit trails. Ethical approval was obtained from the National Institute for Pharmaceutical Research and Development Health Research Ethics Committee prior to the commencement of data collection. Results: This study revealed eight thematic areas underpinning the gaps associated with local vaccine production in Nigeria. Challenges included limited capacity, inadequate research and development, infrastructure deficits, and a sub-optimal environment for vaccine development. Furthermore, the challenges associated with commercialisation and distribution were identified. Findings also revealed a lack of critical factors required for expediting vaccine manufacturing in Nigeria, including poor commitment to collaboration, an absence of sustainability policies and sub-optimal legislation. Conclusion: The study provides insight into systemic and structural barriers to local vaccine production in Nigeria. It identifies key areas requiring urgent intervention, which include funding, infrastructure, human capacity, and regulatory reform. Addressing these gaps through multi-level strategies is critical for improving vaccine self-sufficiency. Evidence from this study can help develop contextual strategies that will expedite vaccine production and Medicines’ Security in Nigeria.
- Open Access
- 25 August 2025
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 5, 1466299
Improving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals
Introduction: In sub-Saharan Africa, the burden of sickle cell disease remains high. With annual sickle cell births of about 150,000, Nigeria is reported to have the highest prevalence of the disease globally. This study aimed to explore the views and perspectives of healthcare professionals regarding access to healthcare services for sickle cell disease.Methods: A quantitative cross-sectional design was employed for this study. Participants comprised healthcare practitioners across Nigeria. A well-structured questionnaire was utilised for data collection. A stratified multistage sampling strategy was used for the study, and respondents were recruited from all the six geographical zones in the country. Data collected were entered into Statistical Package for Social Sciences (SPSS) software version 25. Descriptive and inferential statistical analyses were undertaken. Results were presented in frequencies and percentages.Results: The response rate was 83.5% (1,002/1,200); male and female participants were of similar proportions, as indicated by 51.2% and 48.8%, respectively. A significant proportion of the participants (43.1%) disagreed that development partners have adequately contributed to the funding of sickle cell disease research in Nigeria. The majority of the respondents (81%) indicated that providing special funding for health research can facilitate access to healthcare services for sickle cell patients, whilst a similar proportion (79.2%) disagreed that the government alone bears the responsibility for healthcare initiatives for the disease. A third of the study participants (67.8%) were of the view that current research and development efforts towards sickle cell disease were inadequate.Conclusion: This study describes health professionals' views on access to healthcare for sickle cell, and the findings revealed the criticality of private and development sector funding in reducing the burden of the disease. Furthermore, capacity building at the primary healthcare level would not only ensure access to the basic healthcare needs of patients but could also demystify the condition.
- 25 August 2025
- Published by Frontiers Media SA in Frontiers in Health Services
- Vol. 5, 1466299
Open AccessImproving access to healthcare services for sickle cell disease patients in Nigeria: perspectives and views of healthcare professionals
Introduction: In sub-Saharan Africa, the burden of sickle cell disease remains high. With annual sickle cell births of about 150,000, Nigeria is reported to have the highest prevalence of the disease globally. This study aimed to explore the views and perspectives of healthcare professionals regarding access to healthcare services for sickle cell disease.Methods: A quantitative cross-sectional design was employed for this study. Participants comprised healthcare practitioners across Nigeria. A well-structured questionnaire was utilised for data collection. A stratified multistage sampling strategy was used for the study, and respondents were recruited from all the six geographical zones in the country. Data collected were entered into Statistical Package for Social Sciences (SPSS) software version 25. Descriptive and inferential statistical analyses were undertaken. Results were presented in frequencies and percentages.Results: The response rate was 83.5% (1,002/1,200); male and female participants were of similar proportions, as indicated by 51.2% and 48.8%, respectively. A significant proportion of the participants (43.1%) disagreed that development partners have adequately contributed to the funding of sickle cell disease research in Nigeria. The majority of the respondents (81%) indicated that providing special funding for health research can facilitate access to healthcare services for sickle cell patients, whilst a similar proportion (79.2%) disagreed that the government alone bears the responsibility for healthcare initiatives for the disease. A third of the study participants (67.8%) were of the view that current research and development efforts towards sickle cell disease were inadequate.Conclusion: This study describes health professionals' views on access to healthcare for sickle cell, and the findings revealed the criticality of private and development sector funding in reducing the burden of the disease. Furthermore, capacity building at the primary healthcare level would not only ensure access to the basic healthcare needs of patients but could also demystify the condition.
- Open Access
- 8 August 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1484238
Knowledge and usage patterns of clotrimazole vaginal cream and tablet amongst females: a cross-sectional study
Introduction: Clotrimazole is a broad-spectrum antimycotic agent that is primarily used to treat yeast and other fungal infections. Considering the limited number of medicines available for the treatment of vulvovaginal candidiasis, indiscriminate use of clotrimazole is rapidly emerging as a critical health issue. In Nigeria, where clotrimazole can be obtained without a prescription, there are public health concerns regarding the potential for antimicrobial resistance. This study therefore aimed to assess the knowledge and usage patterns of clotrimazole amongst women.Methods: A cross-sectional study involving 410 adult females in the Federal Capital Territory was conducted using a validated questionnaire. Data collected were analysed using Statistical Package for Social Sciences version 25. Descriptive statistics were used to summarise sociodemographic data, knowledge scores and usage patterns, while inferential statistics (ANOVA and t-test) examined associations between participants’ socio-demographic characteristics and knowledge levels.Results: The study included participants aged 18 years and above. Majority of the respondents learned about clotrimazole in the hospital (68.8%) and pharmacy (63.2%). Using Bloom’s cut off point, none of the participants had good knowledge of clotrimazole, and only about a quarter of the participants (26.1%) reported average knowledge regarding the use of the medicine. The overall mean knowledge score was 6.45 ± 2.43 (range 0–14). About a third of the respondents (31.7%) who had used clotrimazole in the last year reported using the medicine as a contraceptive. There was a statistically significant relationship between the level of education and participants’ knowledge score (p < 0.001).Conclusion: Findings from this study revealed that the participants had poor knowledge regarding clotrimazole use. Inappropriate usage patterns were also observed. These emergent findings have serious implications, particularly regarding the potential for resistance to the medicine.
- 8 August 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1484238
Open AccessKnowledge and usage patterns of clotrimazole vaginal cream and tablet amongst females: a cross-sectional study
Introduction: Clotrimazole is a broad-spectrum antimycotic agent that is primarily used to treat yeast and other fungal infections. Considering the limited number of medicines available for the treatment of vulvovaginal candidiasis, indiscriminate use of clotrimazole is rapidly emerging as a critical health issue. In Nigeria, where clotrimazole can be obtained without a prescription, there are public health concerns regarding the potential for antimicrobial resistance. This study therefore aimed to assess the knowledge and usage patterns of clotrimazole amongst women.Methods: A cross-sectional study involving 410 adult females in the Federal Capital Territory was conducted using a validated questionnaire. Data collected were analysed using Statistical Package for Social Sciences version 25. Descriptive statistics were used to summarise sociodemographic data, knowledge scores and usage patterns, while inferential statistics (ANOVA and t-test) examined associations between participants’ socio-demographic characteristics and knowledge levels.Results: The study included participants aged 18 years and above. Majority of the respondents learned about clotrimazole in the hospital (68.8%) and pharmacy (63.2%). Using Bloom’s cut off point, none of the participants had good knowledge of clotrimazole, and only about a quarter of the participants (26.1%) reported average knowledge regarding the use of the medicine. The overall mean knowledge score was 6.45 ± 2.43 (range 0–14). About a third of the respondents (31.7%) who had used clotrimazole in the last year reported using the medicine as a contraceptive. There was a statistically significant relationship between the level of education and participants’ knowledge score (p < 0.001).Conclusion: Findings from this study revealed that the participants had poor knowledge regarding clotrimazole use. Inappropriate usage patterns were also observed. These emergent findings have serious implications, particularly regarding the potential for resistance to the medicine.
- Open Access
- 3 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0322364
Awareness, knowledge and belief regarding bitter leaf use: A cross-sectional study in Nigeria
Background: Vernonia amygdalina, also known as bitter leaf, is a plant that is widespread in Nigeria. Bitter leaf plant has several medicinal properties, and the plant is also widely used due to its various gastronomic applications. This study aimed to assess awareness, knowledge, and beliefs regarding bitter leaf use. Methods: A cross-sectional study was undertaken in Nigeria. Paper-based questionnaires were administered to participants, and the data were analysed using Statistical Package for Social Sciences. Results: Of the 500 questionnaires that were administered, a total of 401 copies were completed and returned, resulting in a response rate of 80.2%. About two-thirds (65%) of the study participants were females, whilst 35% were males. Almost all the participants (98%) had heard about bitter leaf, the total mean score for knowledge of bitter leaf use amongst the respondents was 4.80 ± 2.14 (Range 0–9). Using the Bloom cut off, only about 11.7% of the population had good knowledge and 27.2% had moderate knowledge regarding bitter leaf. However, more than three-quarters of the sample (79.6%) linked bitter leaf to its glucose lowering properties, towards optimal maintenance of blood sugar levels. The respondents’ sources of information on bitter leaf use were mainly from relatives (88%) and social media (19.9%). Statistically significant findings revealed stronger belief amongst females regarding the employment of bitter leaf as a weight loss intervention (p = 0.042). Conclusion: Although most participants were familiar with the bitter leaf plant, only a few of them had adequate knowledge of its properties. Given its widespread use, a comprehensive understanding is imperative to prevent misuse. Findings from this study indicate that most people rely on informal sources for information about the plant, potentially leading to misconceptions regarding proper use. Consequently, evidence-based public education is needed to promote safe consumption and fully harness the plant’s nutritional and medicinal benefits.
- 3 June 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (6) , e0322364
Open AccessAwareness, knowledge and belief regarding bitter leaf use: A cross-sectional study in Nigeria
Background: Vernonia amygdalina, also known as bitter leaf, is a plant that is widespread in Nigeria. Bitter leaf plant has several medicinal properties, and the plant is also widely used due to its various gastronomic applications. This study aimed to assess awareness, knowledge, and beliefs regarding bitter leaf use. Methods: A cross-sectional study was undertaken in Nigeria. Paper-based questionnaires were administered to participants, and the data were analysed using Statistical Package for Social Sciences. Results: Of the 500 questionnaires that were administered, a total of 401 copies were completed and returned, resulting in a response rate of 80.2%. About two-thirds (65%) of the study participants were females, whilst 35% were males. Almost all the participants (98%) had heard about bitter leaf, the total mean score for knowledge of bitter leaf use amongst the respondents was 4.80 ± 2.14 (Range 0–9). Using the Bloom cut off, only about 11.7% of the population had good knowledge and 27.2% had moderate knowledge regarding bitter leaf. However, more than three-quarters of the sample (79.6%) linked bitter leaf to its glucose lowering properties, towards optimal maintenance of blood sugar levels. The respondents’ sources of information on bitter leaf use were mainly from relatives (88%) and social media (19.9%). Statistically significant findings revealed stronger belief amongst females regarding the employment of bitter leaf as a weight loss intervention (p = 0.042). Conclusion: Although most participants were familiar with the bitter leaf plant, only a few of them had adequate knowledge of its properties. Given its widespread use, a comprehensive understanding is imperative to prevent misuse. Findings from this study indicate that most people rely on informal sources for information about the plant, potentially leading to misconceptions regarding proper use. Consequently, evidence-based public education is needed to promote safe consumption and fully harness the plant’s nutritional and medicinal benefits.
- Open Access
- 24 March 2025
- Published by Frontiers Media SA in Frontiers in Reproductive Health
- Vol. 7, 1488707
Knowledge, attitudes, and practices regarding contraception amongst community pharmacy staff: a cross-sectional study in Nigeria
Introduction: Lack of access to effective contraception methods can lead to an increased prevalence of unintended pregnancies, as well as possible deleterious health consequences. Community pharmacies represent the most accessible gateway for population medicines' and healthcare needs. Regarding contraceptives, they have also been identified as a platform for the provision of additional services, such as complementary counselling. This study aimed at assessing the knowledge, attitudes, and practices of community pharmacy staff towards contraception.Methods: A cross-sectional study was undertaken in the Federal Capital Territory, Nigeria. Data were collected from 315 community pharmacy staff using self-administered questionnaires. The participants' knowledge and attitude scores were categorised using Bloom's cut-off point. Analyses were undertaken using Statistical Package for Social Sciences. The data were analysed using frequency distribution, chi-square, and linear regression at a 5% level of significance.Results: Male participants in the study (165/315, 52.4%) were slightly higher than the female respondents (150/315, 47.6%), and about two-thirds of the study cohort were pharmacists (200/315, 63.5%). The majority of the participants (183/315, 58.1%) had poor knowledge of contraceptive use. A quarter of them (81/315, 25.7%) reported moderate attitudes. Almost all the participants (279/298, 93.6%) indicated recommending contraceptives for married adults, and a significant proportion of them (136/292, 45.5%) were opposed to recommending contraceptives for unmarried adolescents. Study respondents' professional role was also identified as a significant influence on their knowledge of contraceptives and contraception (p < 0.001).Conclusion: Findings from this study revealed poor knowledge and negative attitudes of community pharmacy staff towards contraception. Government and relevant stakeholders can build on these novel findings to reform pertinent contextual policies and practices. This can significantly improve access to contraceptives amongst the populace, and consequently reduce unintended pregnancies alongside possible health and societal implications.
- 24 March 2025
- Published by Frontiers Media SA in Frontiers in Reproductive Health
- Vol. 7, 1488707
Open AccessKnowledge, attitudes, and practices regarding contraception amongst community pharmacy staff: a cross-sectional study in Nigeria
Introduction: Lack of access to effective contraception methods can lead to an increased prevalence of unintended pregnancies, as well as possible deleterious health consequences. Community pharmacies represent the most accessible gateway for population medicines' and healthcare needs. Regarding contraceptives, they have also been identified as a platform for the provision of additional services, such as complementary counselling. This study aimed at assessing the knowledge, attitudes, and practices of community pharmacy staff towards contraception.Methods: A cross-sectional study was undertaken in the Federal Capital Territory, Nigeria. Data were collected from 315 community pharmacy staff using self-administered questionnaires. The participants' knowledge and attitude scores were categorised using Bloom's cut-off point. Analyses were undertaken using Statistical Package for Social Sciences. The data were analysed using frequency distribution, chi-square, and linear regression at a 5% level of significance.Results: Male participants in the study (165/315, 52.4%) were slightly higher than the female respondents (150/315, 47.6%), and about two-thirds of the study cohort were pharmacists (200/315, 63.5%). The majority of the participants (183/315, 58.1%) had poor knowledge of contraceptive use. A quarter of them (81/315, 25.7%) reported moderate attitudes. Almost all the participants (279/298, 93.6%) indicated recommending contraceptives for married adults, and a significant proportion of them (136/292, 45.5%) were opposed to recommending contraceptives for unmarried adolescents. Study respondents' professional role was also identified as a significant influence on their knowledge of contraceptives and contraception (p < 0.001).Conclusion: Findings from this study revealed poor knowledge and negative attitudes of community pharmacy staff towards contraception. Government and relevant stakeholders can build on these novel findings to reform pertinent contextual policies and practices. This can significantly improve access to contraceptives amongst the populace, and consequently reduce unintended pregnancies alongside possible health and societal implications.
- Open Access
- 7 February 2025
- Published by Springer Nature in Malaria Journal
- Vol. 24 (1) , 1-9
Acceptance and affordability of malaria vaccines: issues relating to hesitancy and willingness to pay amongst Nigerian parents of under-five children
Background: With the recent approval of the malaria vaccine by the World Health Organization, it is expected that global acceptance and subsequent uptake of the intervention can help to reduce the burden of the disease in Africa. This study adopted a proactive approach in assessing parents' acceptance of the malaria vaccine, alongside their willingness to pay for the novel public health intervention. Methods: A national cross-sectional survey was undertaken in Nigeria using a questionnaire as the data collection instrument. The study tool was administered to parents of child-bearing age. Descriptive and inferential statistical analyses were performed using the Statistical Package for Social Sciences (SPSS) software version 25. Results: A total of 1413 valid responses were received with male (49.5%) and female (50.5%) participants represented by similar proportions. Close to two-thirds (62.5%) of the participants were between the ages of 31 and 40 years, and 47.4% of the participants were educated up to national diploma level. More than two-thirds (69.6%) of the participants indicated that they were worried about side effects that may be associated with the malaria vaccine. A strong majority (90%) of the participants indicated that the vaccine should be administered at no cost to citizens, while 46.7% of the respondents were willing to pay for the malaria vaccination. Levels of education attained by the respondents influenced their willingness to pay for malaria vaccination. This variable also underpinned participants' reasons for non-acceptance of the vaccine. Those who attained only primary and secondary levels of education were significantly more likely to reject the malaria vaccine because they were against vaccines in general (AOR = 6.63; 95% CI = 1.33 – 39.25; p = 0.021). Conclusion: This study provides critical novel insights which could influence vaccination efforts aimed at reducing the burden of malaria in Nigeria, as well as similar settings.
- 7 February 2025
- Published by Springer Nature in Malaria Journal
- Vol. 24 (1) , 1-9
Open AccessAcceptance and affordability of malaria vaccines: issues relating to hesitancy and willingness to pay amongst Nigerian parents of under-five children
Background: With the recent approval of the malaria vaccine by the World Health Organization, it is expected that global acceptance and subsequent uptake of the intervention can help to reduce the burden of the disease in Africa. This study adopted a proactive approach in assessing parents' acceptance of the malaria vaccine, alongside their willingness to pay for the novel public health intervention. Methods: A national cross-sectional survey was undertaken in Nigeria using a questionnaire as the data collection instrument. The study tool was administered to parents of child-bearing age. Descriptive and inferential statistical analyses were performed using the Statistical Package for Social Sciences (SPSS) software version 25. Results: A total of 1413 valid responses were received with male (49.5%) and female (50.5%) participants represented by similar proportions. Close to two-thirds (62.5%) of the participants were between the ages of 31 and 40 years, and 47.4% of the participants were educated up to national diploma level. More than two-thirds (69.6%) of the participants indicated that they were worried about side effects that may be associated with the malaria vaccine. A strong majority (90%) of the participants indicated that the vaccine should be administered at no cost to citizens, while 46.7% of the respondents were willing to pay for the malaria vaccination. Levels of education attained by the respondents influenced their willingness to pay for malaria vaccination. This variable also underpinned participants' reasons for non-acceptance of the vaccine. Those who attained only primary and secondary levels of education were significantly more likely to reject the malaria vaccine because they were against vaccines in general (AOR = 6.63; 95% CI = 1.33 – 39.25; p = 0.021). Conclusion: This study provides critical novel insights which could influence vaccination efforts aimed at reducing the burden of malaria in Nigeria, as well as similar settings.